Description
Palbociclib is available in India?
Palbociclib is the salt name for the drug sold under the brand name Primcyv. It is for the Treatment of Postmenopausal Patients with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer.
On February 3, 2015, the FDA granted accelerated approval to palbociclib, an inhibitor of cyclin-dependent kinases 4 and 6 (CDK4 and CDK6), for use in combination with letrozole for the treatment of postmenopausal women with estrogen receptor (ER)-positive, HER2-negative advanced breast cancer as initial endocrine-based therapy for their metastatic disease.
Will this product be accessible across all regions of India?
The product – Primcyv (Palbociclib) Capsules will be available across India on request. Palbociclib is available in all the major cities in India – Delhi, Chandigarh, Jodhpur, Patna, Kolkata, Lucknow, Hyderabad, Chennai, Ahmedabad, Bangalore, and Pune. To get or place an order from Aark Pharmaceuticals, a pharma distributor in India, please call us at+91 9999156233, You can also make an inquiry by emailing us at sales@aarkpharma.co.in, sales@aarkpharma.com, WhatsApp: +91 9999156233.
List of available and accessible generic brand of Palbociclib?
Generic brand of Palbociclib available and accessible to patients at an affordable price, at the earliest possible time: Palbace | Hormoclib | PALNAT | Primcyv | Palbo |
NEWS / Updates
- MSN launches generic version of breast cancer drug
- FDA Approves Inavolisib Combo in PIK3CA+ Advanced Breast Cancer
- FDA Approves Inavolisib with Palbociclib and Fulvestrant for Advanced Breast Cancer
Written By
Mr. Sandeep Tomar (D. pharma)
Last updated
12 July 2025 | 07:25 AM (IST)
